secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001104659-23-101272
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx Pharma R&D head Dr. Vijay Modur resigns effective Sept 30, 2023
---------------------------------------------------------------------

- Dr. Vijay Modur, Head of R&D, notified resignation effective September 30, 2023.
- No successor or interim appointment was disclosed in the filing.
- Resignation date of notification is September 15, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923101272/0001104659-23-101272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465923101272/tm2326269d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-101272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer